LEADER 01486nam  2200349Ia 450 
001 9910698890503321
005 20090505161406.0
035   $a(CKB)5470000002396957
035   $a(OCoLC)320270493
035   $a(EXLCZ)995470000002396957
100   $a20090505d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry and FDA staff$b[electronic resource] $ecommercially distributed analyte specific reagents (ASRs), frequently asked questions
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Office of In Vitro Diagnostic Device Evaluation and Safety :$cCenter for Biologics Evaluation and Research,$d[2007]
215   $a13 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 5, 2009).
300   $a"Document issued on: September 14, 2007".
517   $aGuidance for industry and FDA staff 
606   $aBiological reagents
615  0$aBiological reagents.
712 02$aCenter for Devices and Radiological Health (U.S.).$bOffice of In Vitro Diagnostic Device Evaluation and Safety.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698890503321
996   $aGuidance for industry and FDA staff$93451983
997   $aUNINA